How effective must a product be in helping adult smokers quit to overcome the theorized level of harm to youth?Read More
Tags :PMTA
Neil McKeganey explains how companies can make the most of a recent ruling forcing the FDA to reconsider MDOs. Read More
A court ruling requires the agency to take a another look at six marketing applications.Read More
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
Despite onerous requirements on applicants, the agency was happy to cut its own paperwork.Read More
The move follows favorable product reception in the United Kingdom. Read More
The announcement comes as FDA Commissioner Robert Califf attempts to push past several controversies.Read More
A spokesperson for Juul Labs told Reuters that the company is looking at options to protect its business.Read More
